GLUE
Price
$15.78
Change
-$0.39 (-2.41%)
Updated
Dec 1 closing price
Capitalization
1.03B
100 days until earnings call
Intraday BUY SELL Signals
KURA
Price
$11.44
Change
-$0.70 (-5.77%)
Updated
Dec 1 closing price
Capitalization
995.48M
91 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLUE vs KURA

Header iconGLUE vs KURA Comparison
Open Charts GLUE vs KURABanner chart's image
Monte Rosa Therapeutics
Price$15.78
Change-$0.39 (-2.41%)
Volume$545.72K
Capitalization1.03B
Kura Oncology
Price$11.44
Change-$0.70 (-5.77%)
Volume$1.39M
Capitalization995.48M
GLUE vs KURA Comparison Chart in %
GLUE
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLUE vs. KURA commentary
Dec 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and KURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 02, 2025
Stock price -- (GLUE: $15.79 vs. KURA: $11.44)
Brand notoriety: GLUE and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 51% vs. KURA: 69%
Market capitalization -- GLUE: $1.03B vs. KURA: $995.48M
GLUE [@Biotechnology] is valued at $1.03B. KURA’s [@Biotechnology] market capitalization is $995.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, GLUE is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 3 TA indicator(s) are bullish while KURA’s TA Score has 4 bullish TA indicator(s).

  • GLUE’s TA Score: 3 bullish, 4 bearish.
  • KURA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KURA is a better buy in the short-term than GLUE.

Price Growth

GLUE (@Biotechnology) experienced а +0.19% price change this week, while KURA (@Biotechnology) price change was -2.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.58%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +56.80%.

Reported Earning Dates

GLUE is expected to report earnings on Mar 12, 2026.

KURA is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+1.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($1.03B) and KURA($995M) have the same market capitalization . GLUE YTD gains are higher at: 127.522 vs. KURA (31.343). GLUE has higher annual earnings (EBITDA): 23.3M vs. KURA (-192.46M). KURA has more cash in the bank: 631M vs. GLUE (291M). KURA has less debt than GLUE: KURA (19.5M) vs GLUE (41.1M). GLUE has higher revenues than KURA: GLUE (178M) vs KURA (83.3M).
GLUEKURAGLUE / KURA
Capitalization1.03B995M103%
EBITDA23.3M-192.46M-12%
Gain YTD127.52231.343407%
P/E Ratio49.34N/A-
Revenue178M83.3M214%
Total Cash291M631M46%
Total Debt41.1M19.5M211%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUEKURA
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 7 days ago
89%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 28 days ago
90%
Bearish Trend 29 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WSCVX16.22N/A
N/A
North Star Small Cap Value Investor
AMTAX10.82N/A
N/A
AB All Market Real Return A
TSEGX17.25N/A
N/A
Touchstone Sands Cptl Emerg Mkts Gr Inst
MYINX10.15-0.04
-0.39%
NYLI WMC International Rsrch Eq Inv Cl
PASSX59.31-0.65
-1.08%
T. Rowe Price Small-Cap Stock Adv